Join to View Full Profile
Massachusetts General Hospital55 Fruit St.Boston, MA 02114
Phone+1 617-726-7939
Dr. Kim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Geon Kim is an internal medicine specialist based in Boston, MA, with a subspecialty in Hematology/Oncology. He completed his fellowship in Hematology and Medical Oncology in 2021 at the Brigham and Women's Hospital, Massachusetts General Hospital, and Dana-Farber Cancer Institute. He is a Harvard Medical School graduate and completed his residency in Internal Medicine from Massachusetts General Hospital.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2022
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2015 - 2017
Harvard Medical SchoolClass of 2014
Certifications & Licensure
MA State Medical License 2018 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsShoulder balance in Lenke type 2 adolescent idiopathic scoliosis: correlations among radiological indices, cosmetic indices, and patient-reported outcomes.Hyung Rae Lee, Chang Ju Hwang, Sang Yun Seok, Geon Jung Kim, Jae Hwan Cho
Journal of Neurosurgery. Spine. 2024-06-01 - 1 citationsEffect of Pre-Procedural Beta-Blocker on Clinical Outcome after Percutaneous Coronary Intervention in Acute Coronary Syndrome.Bum Sung Kim, Sang Youg Eom, Sung Hea Kim, Hweung Kon Hwang, Jong Seon Park
International Heart Journal. 2019-11-30 - 10 citationsBone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk groupMark Bustoros, Efstathios Kastritis, Romanos Sklavenitis-Pistofidis, Chia Jen Liu, Kalvis Hornburg
American Journal of Hematology. 2019-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
